• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . Genetic Characterization of Influenza A Viruses Circulating in Hong Kong, China, 2023: The first influenza epidemic after th

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2025 Jun 16:2521850.
doi: 10.1080/22221751.2025.2521850. Online ahead of print. Genetic Characterization of Influenza A Viruses Circulating in Hong Kong, China, 2023: The first influenza epidemic after the lifting of 2.5 years of COVID-19 non-pharmaceutical interventions

Jingyuan Bian[SUP] 1 [/SUP], Joshua Fung[SUP] 1 [/SUP], Lam-Kwong Lee[SUP] 1 [/SUP], Wing-Yin Tam[SUP] 1 [/SUP], Leo Chun-Hei Wong[SUP] 1 [/SUP], Cyrus Ka-Wo Wong[SUP] 1 [/SUP], Maverick Yu-Xuan Lau[SUP] 1 [/SUP], Bei Jiang[SUP] 1 [/SUP], Nicky Ho-Laam Tang[SUP] 1 [/SUP], Alex Yat-Man Ho[SUP] 2 [/SUP], Miranda Chong-Yee Yau[SUP] 3 [/SUP], Jason Chi-Ka Cheng[SUP] 4 [/SUP], Kristine Shik Luk[SUP] 2 [/SUP], May Kin-Ping Lee[SUP] 2 [/SUP], Jimmy Yiu-Wing Lam[SUP] 3 [/SUP], Sandy Ka-Yee Chau[SUP] 4 [/SUP], Qing Xiong[SUP] 1 [/SUP], Gilman Kit-Hang Siu[SUP] 1 [/SUP], Franklin Wang-Ngai Chow[SUP] 1 [/SUP]



Affiliations
Free article Abstract

During the COVID-19 pandemic, stringent public health measures led to historically low influenza activity in Hong Kong. However, after these interventions were relaxed in 2023, Influenza A viruses (IAV), including A(H1N1)pdm09 and A(H3N2), rapidly resurfaced. In this study, 1,046 clinical cases collected throughout 2023 underwent comprehensive genomic analysis using Oxford Nanopore Technologies (ONT). Phylogenetic analyses of the assembled genome segments were conducted alongside several global public sequences for comparison. The dataset is comprised of 593 A(H1N1)pdm09 sequences, predominantly of hemagglutinin (HA) subclade 5a.2a and neuraminidase (NA) subclade C.5.3, and 453 A(H3N2) sequences classified mainly as HA subclade 2a.3a.1 and NA subclade B.4.3. Phylogenetic comparisons revealed close genetic relationships between the studied viruses and 30 A(H1N1)pdm09 and 27 A(H3N2) sequences published in other regions during the same time. Additionally, identified amino acid substitutions may affect antigenicity and viral fitness. These findings underscore Hong Kong's high post-COVID-19 influenza diversity and the need for ongoing molecular surveillance to monitor emerging viral variants.

Keywords: A(H1N1)pdm09; A(H3N2); Influenza A virus; Molecular epidemiology; Nanopore sequencing; Phylogenetic analysis; non-pharmaceutical interventions (NPIs).

 
Back
Top Bottom